Silvana Naredi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Silvana Naredi has a total of 134 co-authors. Here are the top co-authors by number of shared publications:
- Lars-Owe D. Koskinen
Department of Clinical Sciences, Neurosciences, Umeå University, Umea, Sweden
19 shared publications - Cecilia M. Lindgren
Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK
8 shared publications Marie Rodling-Wahlström
Department of Surgical and Perioperative Sciences, Anaesthesiology and Intensive Care, UmeåUniversity, Umeå, Sweden
6 shared publications- Magnus Hultin
Affiliation Department of Diagnostics and Intervention, Anesthesiology and Intensive Care, Umeå University, Umeå, Sweden
5 shared publications Magnus Olivecrona
Department of Pharmacology and Clinical Neuroscience, Neurosurgery, Umeå University, Ume , Sweden
5 shared publicationsBertil Rydenhag
Sahlgrenska University Hospital
4 shared publications
Latest Publications
- Open Access
- 18 July 2022
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 146 (5) , 525-536
Long‐term outcomes after aneurysmal subarachnoid hemorrhage: A prospective observational cohort study
Objectives The survival rates for patients affected by aneurysmal subarachnoid hemorrhage (aSAH) have increased in recent years; however, many patients continue to develop cognitive dysfunctions that affect their quality of life. The commonly used outcome measures often fail to identify these cognitive dysfunctions. This study aimed to evaluate the long-term outcomes at 1 and 3 years after aSAH to assess changes over time and relate outcomes to patient characteristics and events during the acute phase. Materials and Methods This prospective observational study included patients that experienced aSAH. Patients were assessed according to the extended Glasgow Outcome Scale, Life Satisfaction Questionnaire, Mayo-Portland Adaptability inventory-4, and Mental Fatigue scale. Results Patients were assessed after 1 year (n = 62) and 3 years (n = 54). At 3 years, the extended Glasgow Outcome Scale score improved in 15% and worsened in 12% of the patients. Mental fatigue was observed in 57% of the patients at 1 year. Patients 60 years of age. Patients with delayed cerebral ischemia during the acute phase reported more dissatisfaction at 3 years, whereas no significant result was seen at 1 year. Conclusions Cognitive dysfunction, especially mental fatigue, is common in patients with aSAH, which affects quality of life and recovery. Patient outcome is a dynamic process developing throughout years after aSAH, involving both improvement and deterioration. This study indicates the importance of longer follow-up periods with broad outcome assessments.
- 18 July 2022
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 146 (5) , 525-536
Open AccessLong‐term outcomes after aneurysmal subarachnoid hemorrhage: A prospective observational cohort study
Objectives The survival rates for patients affected by aneurysmal subarachnoid hemorrhage (aSAH) have increased in recent years; however, many patients continue to develop cognitive dysfunctions that affect their quality of life. The commonly used outcome measures often fail to identify these cognitive dysfunctions. This study aimed to evaluate the long-term outcomes at 1 and 3 years after aSAH to assess changes over time and relate outcomes to patient characteristics and events during the acute phase. Materials and Methods This prospective observational study included patients that experienced aSAH. Patients were assessed according to the extended Glasgow Outcome Scale, Life Satisfaction Questionnaire, Mayo-Portland Adaptability inventory-4, and Mental Fatigue scale. Results Patients were assessed after 1 year (n = 62) and 3 years (n = 54). At 3 years, the extended Glasgow Outcome Scale score improved in 15% and worsened in 12% of the patients. Mental fatigue was observed in 57% of the patients at 1 year. Patients 60 years of age. Patients with delayed cerebral ischemia during the acute phase reported more dissatisfaction at 3 years, whereas no significant result was seen at 1 year. Conclusions Cognitive dysfunction, especially mental fatigue, is common in patients with aSAH, which affects quality of life and recovery. Patient outcome is a dynamic process developing throughout years after aSAH, involving both improvement and deterioration. This study indicates the importance of longer follow-up periods with broad outcome assessments.
- Open Access
- 1 May 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 62-69
Robust Machine Learning in Critical Care — Software Engineering and Medical Perspectives
Using machine learning in clinical practice poses hard requirements on explainability, reliability, replicability and robustness of these systems. Therefore, developing reliable software for monitoring critically ill patients requires close collaboration between physicians and software engineers. However, these two different disciplines need to find own research perspectives in order to contribute to both the medical and the software engineering domain. In this paper, we address the problem of how to establish a collaboration where software engineering and medicine meets to design robust machine learning systems to be used in patient care. We describe how we designed software systems for monitoring patients under carotid endarterectomy, in particular focusing on the process of knowledge building in the research team. Our results show what to consider when setting up such a collaboration, how it develops over time and what kind of systems can be constructed based on it. We conclude that the main challenge is to find a good research team, where different competences are committed to a common goal.
- 1 May 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 62-69
Open AccessRobust Machine Learning in Critical Care — Software Engineering and Medical Perspectives
Using machine learning in clinical practice poses hard requirements on explainability, reliability, replicability and robustness of these systems. Therefore, developing reliable software for monitoring critically ill patients requires close collaboration between physicians and software engineers. However, these two different disciplines need to find own research perspectives in order to contribute to both the medical and the software engineering domain. In this paper, we address the problem of how to establish a collaboration where software engineering and medicine meets to design robust machine learning systems to be used in patient care. We describe how we designed software systems for monitoring patients under carotid endarterectomy, in particular focusing on the process of knowledge building in the research team. Our results show what to consider when setting up such a collaboration, how it develops over time and what kind of systems can be constructed based on it. We conclude that the main challenge is to find a good research team, where different competences are committed to a common goal.
- Open Access
- 1 February 2021
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 143 (2) , 195-205
Association between inflammatory response and outcome after subarachnoid haemorrhage
Objectives Recent reports suggest an association between the inflammatory response after aneurysmal subarachnoid haemorrhage (aSAH) and patients' outcome. The primary aim of this study was to identify a potential association between the inflammatory response after aSAH and 1-year outcome. The secondary aim was to investigate whether the inflammatory response after aSAH could predict the development of delayed cerebral ischaemia (DCI). Materials and methods This prospective observational pilot study included patients with an aSAH admitted to Sahlgrenska University Hospital, Gothenburg, Sweden, between May 2015 and October 2016. The patients were stratified according to the extended Glasgow Outcome Scale (GOSE) as having an unfavourable (score: 1-4) or favourable outcome (score: 5-8). Furthermore, patients were stratified depending on development of DCI or not. Patient data and blood samples were collected and analysed at admission and after 10 days. Results Elevated serum concentrations of inflammatory markers such as tumour necrosis factor-alpha and interleukin (IL)-6, IL-1Ra, C-reactive protein and intercellular adhesion molecule-1 were detected in patients with unfavourable outcome. When adjustments for Glasgow coma scale were made, only IL-1Ra remained significantly associated with poor outcome (p = 0.012). The inflammatory response after aSAH was not predictive of the development of DCI. Conclusion Elevated serum concentrations of inflammatory markers were associated with poor neurological outcome 1-year after aSAH. However, inflammatory markers are affected by many clinical events, and when adjustments were made, only IL-1Ra remained significantly associated with poor outcome. The robustness of these results needs to be tested in a larger trial.
- 1 February 2021
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 143 (2) , 195-205
Open AccessAssociation between inflammatory response and outcome after subarachnoid haemorrhage
Objectives Recent reports suggest an association between the inflammatory response after aneurysmal subarachnoid haemorrhage (aSAH) and patients' outcome. The primary aim of this study was to identify a potential association between the inflammatory response after aSAH and 1-year outcome. The secondary aim was to investigate whether the inflammatory response after aSAH could predict the development of delayed cerebral ischaemia (DCI). Materials and methods This prospective observational pilot study included patients with an aSAH admitted to Sahlgrenska University Hospital, Gothenburg, Sweden, between May 2015 and October 2016. The patients were stratified according to the extended Glasgow Outcome Scale (GOSE) as having an unfavourable (score: 1-4) or favourable outcome (score: 5-8). Furthermore, patients were stratified depending on development of DCI or not. Patient data and blood samples were collected and analysed at admission and after 10 days. Results Elevated serum concentrations of inflammatory markers such as tumour necrosis factor-alpha and interleukin (IL)-6, IL-1Ra, C-reactive protein and intercellular adhesion molecule-1 were detected in patients with unfavourable outcome. When adjustments for Glasgow coma scale were made, only IL-1Ra remained significantly associated with poor outcome (p = 0.012). The inflammatory response after aSAH was not predictive of the development of DCI. Conclusion Elevated serum concentrations of inflammatory markers were associated with poor neurological outcome 1-year after aSAH. However, inflammatory markers are affected by many clinical events, and when adjustments were made, only IL-1Ra remained significantly associated with poor outcome. The robustness of these results needs to be tested in a larger trial.
- Open Access
- 13 June 2020
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 64 (9) , 1335-1342
Cerebral ischemia detection using artificial intelligence (CIDAI)—A study protocol
Background: The onset of cerebral ischemia is difficult to predict in patients with altered consciousness using the methods available. We hypothesize that changes in Heart Rate Variability (HRV), Near‐Infrared Spectroscopy (NIRS), and Electroencephalography (EEG) correlated with clinical data and processed by artificial intelligence (AI) can indicate the development of imminent cerebral ischemia and reperfusion, respectively. This study aimed to develop a method that enables detection of imminent cerebral ischemia in unconscious patients, noninvasively and with the support of AI.Methods: This prospective observational study will include patients undergoing elective surgery for carotid endarterectomy and patients undergoing acute endovascular embolectomy for cerebral arterial embolism. HRV, NIRS, and EEG measurements and clinical information on patient status will be collected and processed using machine learning. The study will take place at Sahlgrenska University Hospital, Gothenburg, Sweden. Inclusion will start in September 2020, and patients will be included until a robust model can be constructed. By analyzing changes in HRV, EEG, and NIRS measurements in conjunction with cerebral ischemia or cerebral reperfusion, it should be possible to train artificial neural networks to detect patterns of impending cerebral ischemia. The analysis will be performed using machine learning with long short‐term memory artificial neural networks combined with convolutional layers to identify patterns consistent with cerebral ischemia and reperfusion.Discussion: Early signs of cerebral ischemia could be detected more rapidly by identifying patterns in integrated, continuously collected physiological data processed by AI. Clinicians could then be alerted, and appropriate actions could be taken to improve patient outcomes.
- 13 June 2020
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 64 (9) , 1335-1342
Open AccessCerebral ischemia detection using artificial intelligence (CIDAI)—A study protocol
Background: The onset of cerebral ischemia is difficult to predict in patients with altered consciousness using the methods available. We hypothesize that changes in Heart Rate Variability (HRV), Near‐Infrared Spectroscopy (NIRS), and Electroencephalography (EEG) correlated with clinical data and processed by artificial intelligence (AI) can indicate the development of imminent cerebral ischemia and reperfusion, respectively. This study aimed to develop a method that enables detection of imminent cerebral ischemia in unconscious patients, noninvasively and with the support of AI.Methods: This prospective observational study will include patients undergoing elective surgery for carotid endarterectomy and patients undergoing acute endovascular embolectomy for cerebral arterial embolism. HRV, NIRS, and EEG measurements and clinical information on patient status will be collected and processed using machine learning. The study will take place at Sahlgrenska University Hospital, Gothenburg, Sweden. Inclusion will start in September 2020, and patients will be included until a robust model can be constructed. By analyzing changes in HRV, EEG, and NIRS measurements in conjunction with cerebral ischemia or cerebral reperfusion, it should be possible to train artificial neural networks to detect patterns of impending cerebral ischemia. The analysis will be performed using machine learning with long short‐term memory artificial neural networks combined with convolutional layers to identify patterns consistent with cerebral ischemia and reperfusion.Discussion: Early signs of cerebral ischemia could be detected more rapidly by identifying patterns in integrated, continuously collected physiological data processed by AI. Clinicians could then be alerted, and appropriate actions could be taken to improve patient outcomes.
- 14 February 2020
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 64 (5) , 566-567
Are available methods for assessment of cerebral perfusion sufficient for scientific studies or not?
- 14 February 2020
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 64 (5) , 566-567
Are available methods for assessment of cerebral perfusion sufficient for scientific studies or not?
- 1 February 2019
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 60, 63-67
Cerebrospinal fluid lactate and neurological outcome after subarachnoid haemorrhage
- 1 February 2019
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 60, 63-67
Cerebrospinal fluid lactate and neurological outcome after subarachnoid haemorrhage
- 14 October 2018
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 63 (3) , 365-372
Speckle tracking‐vs conventional echocardiography for the detection of myocardial injury—A study on patients with subarachnoid haemorrhage
Background: Myocardial injury with regional wall motion abnormalities (RWMA) is common in subarachnoid haemorrhage (SAH). We hypothesized that the diagnostic performance of left ventricular (LV) global and regional longitudinal strain (GLS and RLS, respectively), assessed with speckle tracking echocardiography is superior to standard echocardiography for the detection of myocardial injury in SAH.Methods: Seventy‐one unselected patients with verified SAH were included. Echocardiography was performed within 48 hours after admission. hsTnT was followed daily up to 3 days post‐admission. RWMA, LV ejection fraction (LVEF), GLS and RLS were analysed by two experienced echocardiographists, blinded to the information on plasma hsTnT. A reduced GLS was defined as >−15%. Two cut‐off levels were used for the definition of RLS, ie when segmental strain was >−15% (liberal) or >−11% (conservative) in ≥2 adjacent segments. Myocardial injury was defined as a peak hsTnT ≥90 ng/L.Results: The incidence of myocardial injury was 25%. The hsTnT (median, 25% and 75% percentile) in patients with (a) reduced LV ejection fraction (LVEF <50%, n = 10) was 502 (175‐718), (b) RWMA (n = 12) was 648 (337‐750), (c) reduced GLS (n = 12) was 502 (132‐750) and (d) reduced RLS (n = 42) was 40 (10‐216), respectively. The specificity/sensitivity for LVEF, RWMA, GLS and RLS to detect myocardial injury 98%/50%, 100%/67%, 96%/56% and 54%/94%, respectively. The intra‐ and inter‐observer variability for assessment of RLS was high.Conclusion: The diagnostic performance of GLS by strain imaging is not superior to standard echocardiography for the detection of myocardial injury in SAH. RLS could not reliably detect regional myocardial injury.
- 14 October 2018
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 63 (3) , 365-372
Speckle tracking‐vs conventional echocardiography for the detection of myocardial injury—A study on patients with subarachnoid haemorrhage
Background: Myocardial injury with regional wall motion abnormalities (RWMA) is common in subarachnoid haemorrhage (SAH). We hypothesized that the diagnostic performance of left ventricular (LV) global and regional longitudinal strain (GLS and RLS, respectively), assessed with speckle tracking echocardiography is superior to standard echocardiography for the detection of myocardial injury in SAH.Methods: Seventy‐one unselected patients with verified SAH were included. Echocardiography was performed within 48 hours after admission. hsTnT was followed daily up to 3 days post‐admission. RWMA, LV ejection fraction (LVEF), GLS and RLS were analysed by two experienced echocardiographists, blinded to the information on plasma hsTnT. A reduced GLS was defined as >−15%. Two cut‐off levels were used for the definition of RLS, ie when segmental strain was >−15% (liberal) or >−11% (conservative) in ≥2 adjacent segments. Myocardial injury was defined as a peak hsTnT ≥90 ng/L.Results: The incidence of myocardial injury was 25%. The hsTnT (median, 25% and 75% percentile) in patients with (a) reduced LV ejection fraction (LVEF <50%, n = 10) was 502 (175‐718), (b) RWMA (n = 12) was 648 (337‐750), (c) reduced GLS (n = 12) was 502 (132‐750) and (d) reduced RLS (n = 42) was 40 (10‐216), respectively. The specificity/sensitivity for LVEF, RWMA, GLS and RLS to detect myocardial injury 98%/50%, 100%/67%, 96%/56% and 54%/94%, respectively. The intra‐ and inter‐observer variability for assessment of RLS was high.Conclusion: The diagnostic performance of GLS by strain imaging is not superior to standard echocardiography for the detection of myocardial injury in SAH. RLS could not reliably detect regional myocardial injury.
- 1 June 2018
- Published by Elsevier in Intensive and Critical Care Nursing
- Vol. 46, 32-37
Person-centred care during prolonged weaning from mechanical ventilation, nurses’ views: an interview study
- 1 June 2018
- Published by Elsevier in Intensive and Critical Care Nursing
- Vol. 46, 32-37
Person-centred care during prolonged weaning from mechanical ventilation, nurses’ views: an interview study
- 1 April 2018
- Published by AME Publishing Company in Annals of Pancreatic Cancer
- Vol. 1 (1) , AB014
AB014. S014. Fractional uptake of circulating tumor cells across liver-lung compartments during resections of periampullary cancer aimed at cure
Background: Circulating tumor cells (CTCs) are prognostic for outcome in breast, colon, and prostate cancer and seem to represent promising biomarkers of pancreatic carcinoma as well. The aim of the present study was to demonstrate a statistically significant portal-arterial difference of CTC during resection of periampullary cancer aimed at cure in a limited number of patients. Methods: A commercially available instrument (Isoflux®) was used to quantify blood content of CTC in ten patients with periampullary cancer according to preoperative diagnostics. Portal and arterial blood (each 8–10 mL) were simultaneously collected intra-operatively after surgical dissection before division of the pancreas for tumor removal. Quantitative CTC analyses were performed according to standardized protocols for immune-magnetic enrichment of CTC. Flow cytometry was applied for qualitative evaluations of various CTC markers in seven patients. Results: There was a statistically significant difference in numbers of CTC collected in portal blood [58±43 cells per 100 mL, (±SD)] versus arterial blood (24±22 cells per 100 mL, PConclusions: A significant uptake across liver or lung compartments of potentially malignant CTCs from periampullary carcinoma may represent a model to capture, define and characterize cell clones with high metastatic potential in liver and lung tissues following surgical resections.
- 1 April 2018
- Published by AME Publishing Company in Annals of Pancreatic Cancer
- Vol. 1 (1) , AB014
AB014. S014. Fractional uptake of circulating tumor cells across liver-lung compartments during resections of periampullary cancer aimed at cure
Background: Circulating tumor cells (CTCs) are prognostic for outcome in breast, colon, and prostate cancer and seem to represent promising biomarkers of pancreatic carcinoma as well. The aim of the present study was to demonstrate a statistically significant portal-arterial difference of CTC during resection of periampullary cancer aimed at cure in a limited number of patients. Methods: A commercially available instrument (Isoflux®) was used to quantify blood content of CTC in ten patients with periampullary cancer according to preoperative diagnostics. Portal and arterial blood (each 8–10 mL) were simultaneously collected intra-operatively after surgical dissection before division of the pancreas for tumor removal. Quantitative CTC analyses were performed according to standardized protocols for immune-magnetic enrichment of CTC. Flow cytometry was applied for qualitative evaluations of various CTC markers in seven patients. Results: There was a statistically significant difference in numbers of CTC collected in portal blood [58±43 cells per 100 mL, (±SD)] versus arterial blood (24±22 cells per 100 mL, PConclusions: A significant uptake across liver or lung compartments of potentially malignant CTCs from periampullary carcinoma may represent a model to capture, define and characterize cell clones with high metastatic potential in liver and lung tissues following surgical resections.
- Open Access
- 27 May 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 1-9
Leptin levels after subarachnoid haemorrhage are gender dependent
Subarachnoid hemorrhage (SAH) is a neurological disease where the majority of the patients are critically ill. The adipokine leptin has in cerebral emergencies been related to severity of disease and to adverse outcome. The aim of this study was to examine leptin levels over time after SAH and associations to gender, age, body mass index, severity of disease, parenteral lipids, systemic organ failure and outcome. Prospective observational study in 56 patients. Leptin was obtained 0–240 h after SAH, in 48 h intervals. Severity of disease was assessed with the Hunt and Hess score, organ failure with the sequential organ failure assessment score, and outcome with Glasgow outcome scale. Leptin levels in the SAH group were compared with controls from the same geographical area. At admission, Leptin was significantly higher in SAH patients compared to controls, both in female (28.6 ± 25.6 vs 13.0 ± 2.3 ng/mL, p = 0.001) and male patients (13.3 ± 8.4 vs 4.3 ± 0.7 ng/mL, p = 0.001). Leptin levels remained stable over time. Female patients had significantly higher leptin levels than male patients, and deceased female patients had higher leptin levels than female survivors (85.5 ± 20.5 vs 50.5 ± 34.6, n = 4/35, p < 0.05). Leptin levels did not differ between male survivors and non-survivors. Leptin levels were not associated with severity of disease, organ failure or parenteral lipids. Leptin levels were significantly higher in both male and female patients compared to controls. Higher leptin levels were related to outcome and organ failure in women but not in men. When analysing leptin levels gender-related differences should be considered.
- 27 May 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 1-9
Open AccessLeptin levels after subarachnoid haemorrhage are gender dependent
Subarachnoid hemorrhage (SAH) is a neurological disease where the majority of the patients are critically ill. The adipokine leptin has in cerebral emergencies been related to severity of disease and to adverse outcome. The aim of this study was to examine leptin levels over time after SAH and associations to gender, age, body mass index, severity of disease, parenteral lipids, systemic organ failure and outcome. Prospective observational study in 56 patients. Leptin was obtained 0–240 h after SAH, in 48 h intervals. Severity of disease was assessed with the Hunt and Hess score, organ failure with the sequential organ failure assessment score, and outcome with Glasgow outcome scale. Leptin levels in the SAH group were compared with controls from the same geographical area. At admission, Leptin was significantly higher in SAH patients compared to controls, both in female (28.6 ± 25.6 vs 13.0 ± 2.3 ng/mL, p = 0.001) and male patients (13.3 ± 8.4 vs 4.3 ± 0.7 ng/mL, p = 0.001). Leptin levels remained stable over time. Female patients had significantly higher leptin levels than male patients, and deceased female patients had higher leptin levels than female survivors (85.5 ± 20.5 vs 50.5 ± 34.6, n = 4/35, p < 0.05). Leptin levels did not differ between male survivors and non-survivors. Leptin levels were not associated with severity of disease, organ failure or parenteral lipids. Leptin levels were significantly higher in both male and female patients compared to controls. Higher leptin levels were related to outcome and organ failure in women but not in men. When analysing leptin levels gender-related differences should be considered.